Crossmark

Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis

Published Online: 2015-07-20

Authors

Bao, Chenchen

Conde, João

Curtin, James

Artzi, Natalie

Tian, Furong

Cui, Daxiang
License Information

Text and Data Mining valid from 2015-07-20

Version of Record valid from 2015-07-20
More Information

Article History

Received: 1 April 2015

Accepted: 23 June 2015

First Online: 20 July 2015

Competing interests

: The authors declare no competing financial interests.

Document is current